Medlab NanoCelle™ D3 hormone blood level absorption study in healthy adult volunteers.

Medlab Clinical Ltd0 个研究点目标入组 8 人开始时间: 2018年7月16日最近更新: 2020年11月16日

适应症

试验速览

暂无简介。

•1.Participants greater than or equal to 18 years of age at time of entry on study;
•2.No evidence or documented history of a chronic disease;
•3.Cognitive ability to understand informed consent process and to give informed consent to the experimental treatment;

•Any clinically relevant abnormal findings which, in the opinion of the investigators / clinicians, may put the participant at risk of adverse events because of participation in the clinical trial including:
•1.Previous history of abnormal blood results i.e., FBE, U and E Liver Function Tests and vital signs;
•2.Use of vitamin or mineral supplements 1 week before the study and or known adverse side effects to supplements;
•3.Use of pharmaceutical drugs (prescribed or over-the-counter);
•4.Female participants who are lactating or pregnant or planning to become pregnant;
•5.The current use of any nicotine products including:
•i)nicotine patches / gum;
•ii)tobacco smoking;
•6.History of alcohol or substance abuse including the use of any illicit drugs;
•7.Presence of chronic/acute illnesses including hypertension, high cholesterol, diabetes, obesity, irritable bowel syndrome, inflammatory bowel disease, coeliac disease, sarcoidosis, hyperparathyroidism, histoplasmosis.
•8.Any psychiatric disorders by history or examination that would prevent completion of the study or result in possible adverse events for the participant [i.e. suicide thoughts or euthanasia requests]
•9.Vegetarianism

发起方